(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(2.16%) $83.11
(1.98%) $1.752
(1.90%) $2 254.80
(1.41%) $25.10
(1.45%) $922.85
(0.38%) $0.927
(0.71%) $10.84
(0.10%) $0.792
(0.14%) $92.57
Live Chart Being Loaded With Signals
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases...
Stats | |
---|---|
Today's Volume | 376 709 |
Average Volume | 15 693.00 |
Market Cap | 12.04M |
EPS | $-0.820 ( 2023-11-13 ) |
Next earnings date | ( $-2.10 ) 2024-04-04 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.320 |
ATR14 | $0.0300 (1.33%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-23 | Voi Maurizio | Buy | 10 000 | Stock Option (right to buy) |
2024-01-23 | Kim Jason S. | Buy | 10 000 | Stock Option (right to buy) |
2024-01-23 | Poma Eric E | Buy | 23 333 | Stock Option (right to buy) |
2023-10-31 | Voi Maurizio | Buy | 11 333 | Stock Option (right to buy) |
2023-10-27 | Selick Harold E | Buy | 1 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
99.78 |
Last 98 transactions |
Buy: 13 597 504 | Sell: 1 223 834 |
Volume Correlation
Molecular Templates Inc Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Molecular Templates Inc Correlation - Currency/Commodity
Molecular Templates Inc Financials
Annual | 2022 |
Revenue: | $19.75M |
Gross Profit: | $11.95M (60.51 %) |
EPS: | $-1.650 |
Q3 | 2023 |
Revenue: | $6.80M |
Gross Profit: | $5.30M (77.93 %) |
EPS: | $0.820 |
Q2 | 2023 |
Revenue: | $6.63M |
Gross Profit: | $-6.79M (-102.40 %) |
EPS: | $-2.89 |
Q1 | 2023 |
Revenue: | $33.63M |
Gross Profit: | $14.59M (43.37 %) |
EPS: | $0.150 |
Financial Reports:
No articles found.
Molecular Templates Inc
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developing MT-5111, an ETB candidate that is in Phase I clinical trial for the treatment of HER2-positive cancers; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory myeloma patients; and MT-6402 in that is in Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients. Its pipeline of ETBs in development for other targets, including CTLA-4, TIGIT, TROP2, BCMA, SLAMF-7, and CD45. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators